International Clinical Trial: An open label, single arm study of the safety and efficacy of DTG/3TC in therapy-naive HIV-1 infected adolescents

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (EUCTR2025-000361-93-Outside-EU/EEA) titled 'An open label, single arm study of the safety and efficacy of DTG/3TC in therapy-naive HIV-1 infected adolescents' on Aug. 8.

Study Type: Interventional clinical trial of medicinal product

Study Design: Controlled: no Randomised: no Open: yes Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Other: no Number of treatment arms in the trial: 1

Primary Sponsor: ViiV Healthcare UK Limited

Condition: Human Immunodeficiency Virus - 1 (HIV-1) infection Therapeutic area: Diseases [C] - Immune Sys...